JOINT FILING AGREEMENTJoint Filing Agreement • August 20th, 2021 • Lind Global Fund II LP • Pharmaceutical preparations
Contract Type FiledAugust 20th, 2021 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.01 per share, of EyeGate Pharmaceuticals, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • August 17th, 2021 • Lind Global Macro Fund LP • Pharmaceutical preparations
Contract Type FiledAugust 17th, 2021 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.01 per share, of EyeGate Pharmaceuticals, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.